Report Detail
Global (United States, European Union and China) Anti Obesity Drugs Market Research Report 2019-2025
- RnM3470775 |
- 30 May, 2019 |
- Global |
- 129 Pages |
- QYResearch |
- Pharma & Healthcare
In 2019, the market size of Anti Obesity Drugs is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Anti Obesity Drugs.
This report studies the global market size of Anti Obesity Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Anti Obesity Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Pfizer
Merck
Roche
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Novo Nordisk
Eisai
Norgine
Arena Pharmaceuticals
Orexigen Therapeutics
Vivus
Alizyme
Rhythm Pharmaceuticals
Shionogi
Zafgan
Market Segment by Product Type
Oral Medicine
Diet Patch
Diet Tea
Market Segment by Application
Men
Women
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Anti Obesity Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Anti Obesity Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Anti Obesity Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Anti Obesity Drugs Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Oral Medicine
- 1.3.3 Diet Patch
- 1.3.4 Diet Tea
- 1.4 Market Segment by Application
- 1.4.1 Global Anti Obesity Drugs Market Share by Application (2019-2025)
- 1.4.2 Men
- 1.4.3 Women
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Anti Obesity Drugs Market Size
- 2.1.1 Global Anti Obesity Drugs Revenue 2014-2025
- 2.1.2 Global Anti Obesity Drugs Sales 2014-2025
- 2.2 Anti Obesity Drugs Growth Rate by Regions
- 2.2.1 Global Anti Obesity Drugs Sales by Regions 2014-2019
- 2.2.2 Global Anti Obesity Drugs Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Anti Obesity Drugs Sales by Manufacturers
- 3.1.1 Anti Obesity Drugs Sales by Manufacturers 2014-2019
- 3.1.2 Anti Obesity Drugs Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Anti Obesity Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Anti Obesity Drugs Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Anti Obesity Drugs Market Concentration Ratio (CR5 and HHI)
- 3.3 Anti Obesity Drugs Price by Manufacturers
- 3.4 Key Manufacturers Anti Obesity Drugs Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Anti Obesity Drugs Market
- 3.6 Key Manufacturers Anti Obesity Drugs Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Oral Medicine Sales and Revenue (2014-2019)
- 4.1.2 Diet Patch Sales and Revenue (2014-2019)
- 4.1.3 Diet Tea Sales and Revenue (2014-2019)
- 4.2 Global Anti Obesity Drugs Sales Market Share by Type
- 4.3 Global Anti Obesity Drugs Revenue Market Share by Type
- 4.4 Anti Obesity Drugs Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Anti Obesity Drugs Sales by Application
6 United States
- 6.1 United States Anti Obesity Drugs Breakdown Data by Company
- 6.2 United States Anti Obesity Drugs Breakdown Data by Type
- 6.3 United States Anti Obesity Drugs Breakdown Data by Application
7 European Union
- 7.1 European Union Anti Obesity Drugs Breakdown Data by Company
- 7.2 European Union Anti Obesity Drugs Breakdown Data by Type
- 7.3 European Union Anti Obesity Drugs Breakdown Data by Application
8 China
- 8.1 China Anti Obesity Drugs Breakdown Data by Company
- 8.2 China Anti Obesity Drugs Breakdown Data by Type
- 8.3 China Anti Obesity Drugs Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Anti Obesity Drugs Breakdown Data by Company
- 9.2 Rest of World Anti Obesity Drugs Breakdown Data by Type
- 9.3 Rest of World Anti Obesity Drugs Breakdown Data by Application
- 9.4 Rest of World Anti Obesity Drugs Breakdown Data by Countries
- 9.4.1 Rest of World Anti Obesity Drugs Sales by Countries
- 9.4.2 Rest of World Anti Obesity Drugs Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Pfizer
- 10.1.1 Pfizer Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Anti Obesity Drugs
- 10.1.4 Anti Obesity Drugs Product Introduction
- 10.1.5 Pfizer Recent Development
- 10.2 Merck
- 10.2.1 Merck Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Anti Obesity Drugs
- 10.2.4 Anti Obesity Drugs Product Introduction
- 10.2.5 Merck Recent Development
- 10.3 Roche
- 10.3.1 Roche Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Anti Obesity Drugs
- 10.3.4 Anti Obesity Drugs Product Introduction
- 10.3.5 Roche Recent Development
- 10.4 GlaxoSmithKline
- 10.4.1 GlaxoSmithKline Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Anti Obesity Drugs
- 10.4.4 Anti Obesity Drugs Product Introduction
- 10.4.5 GlaxoSmithKline Recent Development
- 10.5 AstraZeneca
- 10.5.1 AstraZeneca Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Anti Obesity Drugs
- 10.5.4 Anti Obesity Drugs Product Introduction
- 10.5.5 AstraZeneca Recent Development
- 10.6 Boehringer Ingelheim
- 10.6.1 Boehringer Ingelheim Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Anti Obesity Drugs
- 10.6.4 Anti Obesity Drugs Product Introduction
- 10.6.5 Boehringer Ingelheim Recent Development
- 10.7 Novo Nordisk
- 10.7.1 Novo Nordisk Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Anti Obesity Drugs
- 10.7.4 Anti Obesity Drugs Product Introduction
- 10.7.5 Novo Nordisk Recent Development
- 10.8 Eisai
- 10.8.1 Eisai Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Anti Obesity Drugs
- 10.8.4 Anti Obesity Drugs Product Introduction
- 10.8.5 Eisai Recent Development
- 10.9 Norgine
- 10.9.1 Norgine Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Anti Obesity Drugs
- 10.9.4 Anti Obesity Drugs Product Introduction
- 10.9.5 Norgine Recent Development
- 10.10 Arena Pharmaceuticals
- 10.10.1 Arena Pharmaceuticals Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Anti Obesity Drugs
- 10.10.4 Anti Obesity Drugs Product Introduction
- 10.10.5 Arena Pharmaceuticals Recent Development
- 10.11 Orexigen Therapeutics
- 10.12 Vivus
- 10.13 Alizyme
- 10.14 Rhythm Pharmaceuticals
- 10.15 Shionogi
- 10.16 Zafgan
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Anti Obesity Drugs Sales Channels
- 11.2.2 Anti Obesity Drugs Distributors
- 11.3 Anti Obesity Drugs Customers
12 Market Forecast
- 12.1 Global Anti Obesity Drugs Sales and Revenue Forecast 2019-2025
- 12.2 Global Anti Obesity Drugs Sales Forecast by Type
- 12.3 Global Anti Obesity Drugs Sales Forecast by Application
- 12.4 Anti Obesity Drugs Forecast by Regions
- 12.4.1 Global Anti Obesity Drugs Sales Forecast by Regions 2019-2025
- 12.4.2 Global Anti Obesity Drugs Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Anti Obesity Drugs . Industry analysis & Market Report on Anti Obesity Drugs is a syndicated market report, published as Global (United States, European Union and China) Anti Obesity Drugs Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Anti Obesity Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
